StockVS

NASDAQ · Shell Companies · USD

GP-Act III Acquisition Corp. (GPAT) Stock Analysis

GP-Act III Acquisition Corp. (GPAT) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 20, 2026

GPAT

$11.08

$0.00 (0.00%)

Oct 20, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare GPAT with… →

GPAT Key Statistics

As of Oct 20, 2026
Trading
Open
$11.08
Previous Close
$11.08
52-Week Range
10.57–12.00
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.00
Valuation
Market Cap
$179.07M
P/E Ratio
44.32
EPS (ttm)Profit attributable to each share over the last twelve months.
0.25
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
$11.89M+37.13%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
16.16M
1-Year Return
+4.14%
Dividend and dates
Avg Volume
10.39K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 20, 2026, GPAT closed at $11.08, +4.14% over 1 year.

GP-Act III Acquisition Corp. (GPAT) has a market capitalization of $179.07M.

In fiscal 2025, GPAT reported revenue of $0.00.

GPAT Stock Return by Calendar Year

GP-Act III Acquisition Corp. (GPAT) return since Jul 2024: what $10,000 became

1 year
$10,000 $10,414
+4.14%
Since Jul 2024
$10,000 $11,091
+10.91%

If you had invested $10,000 in GP-Act III Acquisition Corp. (GPAT) at the close on July 2, 2024, the earliest close on record here, it would have been worth $11,091 at the close on October 20, 2026: +10.91% in total, +4.61% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+3.65%
2025+5.42%
2024 (partial year)+1.50%

As of October 20, 2026.

GPAT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00$11.89M—
2024$0.00$8.67M—
2023$0.00−$14.04K—
2022$0.00−$30.84K—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$551.92K$11.89M—
2024$0.00—−$564.97K$8.67M—
2023$0.00—−$14.04K−$14.04K—
2022$0.00—−$30.84K−$30.84K—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

GPAT Valuation vs Shell Companies Median

Median of 309 stocks
MetricGPATShell Companies medianvs median
P/E44.3249.1610% below

Medians across 309 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

The market values GP-Act III Acquisition Corp. (GPAT) at $179.07M. It is classified in the Shell Companies industry, within the Financial Services sector.

The most recent close on file for GPAT is $11.08, dated October 20, 2026. The close was unchanged from the previous session. Over the past 52 weeks the price has ranged from $10.57 to $12.00. The latest close sits 4.82% above that 52-week low.

Financial Health

In fiscal 2025, GP-Act III Acquisition Corp. reported revenue of $0.00. Net income for the same year was $11.89M. That is +37.13% against the prior fiscal year. Earnings per share on a trailing basis come to 0.25.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 44.32. That is 9.84% below the Shell Companies median of 49.16. 309 Shell Companies companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at −0. Daily returns over the trailing 2 years annualize to a volatility of 4.7%. Over the trailing twelve months the total return is +4.14%. The stored price history starts on July 2, 2024, and the total return since then is +10.91%.

Growth & Income

The record shows no dividend for GPAT.

The record holds one complete calendar year, 2025, which returned +5.42%. 2026 is still running; the total return is +3.65% year to date.

Peer Comparison

GP-Act III Acquisition Corp. (GPAT) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
GP-Act III Acquisition Corp. GPAT $179.07M 44.3
Vylor Inc. VYLR $49.89B 106.8
Drugs Made In America Acquisition II Corp. DMII $649.10M 34.0
Churchill Capital Corp XI CCXI $621.61M —

The Shell Companies industry average P/E ratio is 49.2x. GP-Act III Acquisition Corp. trades at a P/E of 44.3.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 20, 2026.

Related Shell Companies Stocks

View all Shell Companies stocks →

Popular Financial Services Stocks

View all Financial Services stocks →

About GP-Act III Acquisition Corp.

GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

Visit website →